secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2023-02-16T23:59:59+00:00
Accession:  0001437749-23-003575
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health reports Q4 EPS $0.27, down from $0.38; FY revenue +7% but EPS $1.27 vs $1.46
--------------------------------------------------------------------------------

- Q4 diluted EPS $0.27 (vs $0.38 in Q4 2021); full-year 2022 diluted EPS $1.27 (vs $1.46).
- FY 2022 revenue grew 7% year-over-year driven by core Human Understanding Program; Canadian ops phase-out partially offset.
- $2.6M reclassification from substantial liquidation of Canadian subsidiary impacted other expense.
- Capital allocation: $21.0M dividends, $27.6M share repurchases, $12.2M innovation/growth in 2022.
- New client wins including St. Bernards Healthcare; received Best in KLAS 2023 Award for Patient Experience Improvement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774923003575/0001437749-23-003575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774923003575/nrc20230215_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-003575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer